|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
43
|
|
pubmed:dateCreated |
1980-5-23
|
|
pubmed:abstractText |
The controlled clinical trial is reported of a new three-stage oral contraceptive which has meanwhile been introduced on to the market under the trade name Triquilar. Triquilar has a reliable contraceptive action: no pregnancy occurred in 8068 treatment cycles. In spite of the very low doses of estrogen and gestagen--Triquilar contains the lowest total quantity of steroids of all available preparations--the multistage structure guarantees an outstanding cycle control and a particularly good general tolerance. The reasons are discussed which today support the use of an oral contraceptive with the lowest possible amounts of the two hormone components.
|
|
pubmed:keyword |
http://linkedlifedata.com/resource/pubmed/keyword/Bleeding,
http://linkedlifedata.com/resource/pubmed/keyword/Central Nervous System Effects,
http://linkedlifedata.com/resource/pubmed/keyword/Clinical Research,
http://linkedlifedata.com/resource/pubmed/keyword/Contraception,
http://linkedlifedata.com/resource/pubmed/keyword/Contraception Research,
http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Methods,
http://linkedlifedata.com/resource/pubmed/keyword/Diseases,
http://linkedlifedata.com/resource/pubmed/keyword/Family Planning,
http://linkedlifedata.com/resource/pubmed/keyword/Female Contraception,
http://linkedlifedata.com/resource/pubmed/keyword/Gastrointestinal Effects,
http://linkedlifedata.com/resource/pubmed/keyword/METRORRHAGIA,
http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives,
http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives, Combined,
http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives, Phasic,
http://linkedlifedata.com/resource/pubmed/keyword/Research Methodology,
http://linkedlifedata.com/resource/pubmed/keyword/Signs And Symptoms
|
|
pubmed:language |
ger
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0341-3098
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
26
|
|
pubmed:volume |
121
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1421-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:119912-Blood Pressure,
pubmed-meshheading:119912-Cervix Mucus,
pubmed-meshheading:119912-Contraceptives, Oral,
pubmed-meshheading:119912-Contraceptives, Oral, Hormonal,
pubmed-meshheading:119912-Drug Evaluation,
pubmed-meshheading:119912-Ethinyl Estradiol,
pubmed-meshheading:119912-Female,
pubmed-meshheading:119912-Humans,
pubmed-meshheading:119912-Menstruation,
pubmed-meshheading:119912-Norgestrel,
pubmed-meshheading:119912-Ovulation
|
|
pubmed:year |
1979
|
|
pubmed:articleTitle |
[The first three-stage preparation for hormonal contraception. Clinical results (author's transl)].
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|
